Variant report
Variant | nsv551016 |
---|---|
Chromosome Location | chr10:56817554-56877760 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr10:56856112..56857067-chr10:57023573..57024305,2 | MCF-7 | breast: | |
2 | chr10:56860242..56861881-chr10:56864566..56866178,2 | K562 | blood: | |
3 | chr10:56860242..56861881-chr10:56864566..56866178,2 | K562 | blood: | |
4 | chr10:56851202..56852127-chr10:57023430..57024403,6 | MCF-7 | breast: | |
5 | chr10:56848923..56849830-chr22:31212899..31213539,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs180894503 | chr10:56824008-56824009 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs571660326 | chr10:56824011-56824012 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs572503456 | chr10:56824072-56824073 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs530611219 | chr10:56824136-56824137 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs11004719 | chr10:56824144-56824145 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs147324021 | chr10:56824152-56824153 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs140984905 | chr10:56824173-56824174 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs566438701 | chr10:56824196-56824197 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs10825453 | chr10:56824228-56824229 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs10430541 | chr10:56824247-56824248 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs543834376 | chr10:56824271-56824272 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs575290087 | chr10:56824286-56824287 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs144622450 | chr10:56824289-56824290 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs562116952 | chr10:56824308-56824309 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs557621854 | chr10:56824329-56824330 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs574299170 | chr10:56824331-56824332 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs146259553 | chr10:56824345-56824346 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs145695602 | chr10:56824362-56824363 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs559798132 | chr10:56824376-56824377 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs115865745 | chr10:56824430-56824431 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs545114644 | chr10:56824431-56824432 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs565377168 | chr10:56824475-56824476 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs376654492 | chr10:56824478-56824479 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs10825454 | chr10:56824484-56824485 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
25 | rs567079997 | chr10:56824494-56824495 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs529839143 | chr10:56824543-56824544 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs77388026 | chr10:56824587-56824588 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs1922158 | chr10:56824631-56824632 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs538608847 | chr10:56824642-56824643 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs186244299 | chr10:56824651-56824652 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs189155443 | chr10:56824690-56824691 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs11004720 | chr10:56824723-56824724 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
33 | rs113727950 | chr10:56824755-56824756 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs3858273 | chr10:56824889-56824890 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs78536933 | chr10:56824894-56824895 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs11004721 | chr10:56824909-56824910 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs543259275 | chr10:56824948-56824949 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs553613469 | chr10:56825083-56825084 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs181361307 | chr10:56825142-56825143 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs573485462 | chr10:56825153-56825154 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs4472838 | chr10:56825154-56825155 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs565172773 | chr10:56825209-56825210 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs185574899 | chr10:56825216-56825217 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs190726071 | chr10:56825274-56825275 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs148963478 | chr10:56825291-56825292 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs142858820 | chr10:56825308-56825309 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs80228685 | chr10:56825319-56825320 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs546507852 | chr10:56825345-56825346 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs3905359 | chr10:56825358-56825359 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs370984419 | chr10:56825382-56825383 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Melanoma | 18172304 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 18632612 | CNVD |
Autism | 18414403 | CNVD |
Cockayne syndrome | 18421352 | CNVD |
Glioblastoma | 16823260 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Neuroblastoma | 17533364 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Glioma | 21971842 | CNVD |
Cancer | 21637783 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Obesity | 21956041 | CNVD |
Developmental delay | 21948486 | CNVD |
Intellectual disability | 21948486 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Autism | 20841430 | CNVD |
Mental retardation | 17124404 | CNVD |
Epilepsy | 20923578 | CNVD |
Prostate cancer | 16573809 | CNVD |
Schizophrenia | 19329560 | CNVD |
Heart failure | 18772530 | CNVD |
Heart failure | 18854381 | CNVD |
Hyperglycemia | 19060297 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Usher syndrome | 20538994 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Autism | 20858243 | CNVD |
Breast cancer | 22522925 | CNVD |
Usher type I cohort | 17277737 | CNVD |
Usher type I cohort | 21436283 | CNVD |
Leukemia | 21357790 | CNVD |
Medulloblastoma | 22832581 | CNVD |
small cell lung cancer | 17426248 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:56824000-56825800 | Enhancers | HepG2 | liver |
2 | chr10:56840400-56841000 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
3 | chr10:56840800-56841200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
4 | chr10:56841000-56841200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
5 | chr10:56841200-56849000 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
6 | chr10:56847200-56847600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
7 | chr10:56849000-56849200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
8 | chr10:56849000-56849200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
9 | chr10:56849200-56849400 | Flanking Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
10 | chr10:56859800-56860200 | Active TSS | ES-UCSF4 Cell Line | embryonic stem cell |
11 | chr10:56868400-56868800 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
12 | chr10:56868600-56869000 | Enhancers | HMEC | breast |